TP53 and cancer: Therefore, nanoceria-induced apoptosis in MCF7 cells appears to be driven by a coordinated interplay between oxidative stress, p53-mediated mitochondrial signaling, and ROS-induced mitochondrial dysfunction, highlighting mitochondrial redox imbalance as a potential therapeutic target in cancer treatment.